加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
KTB2240 CheKine™ 脂肪酸合成酶(FAS)活性检测试剂盒(微量法) Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma 11 Leukemia
KTB2240 CheKine™ 脂肪酸合成酶(FAS)活性检测试剂盒(微量法) Targeting ZDHHC21/FASN axis for the treatment of diffuse large B-cell lymphoma 11 Leukemia
KTB2250 CheKine™ 高密度脂蛋白(HDL-C)含量检测试剂盒(微量法) Berberine attenuates cognitive dysfunction and hippocampal apoptosis in rats with prediabetes 3 Chemical Biology & Drug Design
KTB2250 CheKine™ 高密度脂蛋白(HDL-C)含量检测试剂盒(微量法) Irisin and Triglyceride Glucose Index as Markers of Dyslipidemia in Young Adults 2 Indian Journal of Clinical Biochemistry
KTB2250 CheKine™ 高密度脂蛋白(HDL-C)含量检测试剂盒(微量法) Carica papaya Reduces Muscle Insulin Resistance via IR/GLUT4 Mediated Signaling Mechanisms in High Fat Diet and Streptozotocin-Induced Type-2 Diabetic Rats 8 Antioxidants
KTB2250 CheKine™ 高密度脂蛋白(HDL-C)含量检测试剂盒(微量法) Allicin alleviates coronary atherosclerosis of mice via endothelial nitric oxide synthase (eNOS)/nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase … 3 Applied Biological Chemistry
KTB2250 CheKine™ 高密度脂蛋白(HDL-C)含量检测试剂盒(微量法) Allicin alleviates coronary atherosclerosis of mice via endothelial nitric oxide synthase (eNOS)/nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase … 5 Applied Biological Chemistry
KTB2260 CheKine™ 低密度脂蛋白(LDL-C)含量检测试剂盒(微量法) Carica papaya Reduces Muscle Insulin Resistance via IR/GLUT4 Mediated Signaling Mechanisms in High Fat Diet and Streptozotocin-Induced Type-2 Diabetic Rats 8 Antioxidants
KTB2260 CheKine™ 低密度脂蛋白(LDL-C)含量检测试剂盒(微量法) Irisin and Triglyceride Glucose Index as Markers of Dyslipidemia in Young Adults 2 Indian Journal of Clinical Biochemistry
KTB2260 CheKine™ 低密度脂蛋白(LDL-C)含量检测试剂盒(微量法) Allicin alleviates coronary atherosclerosis of mice via endothelial nitric oxide synthase (eNOS)/nuclear factor erythroid 2-related factor (Nrf2)/heme oxygenase … 5 Applied Biological Chemistry
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部